Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinsonʼs disease (EASE LID 3) - Oertel, W; Eggert, K; Pahwa, R (Mov Disord, 2017)
et al.